advertisement
Inoue T 19
Showing records 1 to 19 | Display all abstracts from Inoue T60687 p38 MAP Kinase Inhibitor Suppresses Transforming Growth Factor-β2-Induced Type 1 Collagen Production in Trabecular Meshwork Cells
Inoue-Mochita M
PLoS ONE 2015; 10: e0120774
60077 Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study
Tanihara H
Acta Ophthalmologica 2015; 93: e254-e260
60081 Evaluation of filtering blebs exhibiting transconjunctival oozing using anterior segment optical coherence tomography
Nakashima K; Inoue T
Graefe's Archive for Clinical and Experimental Ophthalmology 2015; 253: 439-445
60687 p38 MAP Kinase Inhibitor Suppresses Transforming Growth Factor-β2-Induced Type 1 Collagen Production in Trabecular Meshwork Cells
Inoue T
PLoS ONE 2015; 10: e0120774
60077 Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study
Inoue T; Yamamoto T
Acta Ophthalmologica 2015; 93: e254-e260
60687 p38 MAP Kinase Inhibitor Suppresses Transforming Growth Factor-β2-Induced Type 1 Collagen Production in Trabecular Meshwork Cells
Fujimoto T
PLoS ONE 2015; 10: e0120774
60081 Evaluation of filtering blebs exhibiting transconjunctival oozing using anterior segment optical coherence tomography
Fukushima A
Graefe's Archive for Clinical and Experimental Ophthalmology 2015; 253: 439-445
60687 p38 MAP Kinase Inhibitor Suppresses Transforming Growth Factor-β2-Induced Type 1 Collagen Production in Trabecular Meshwork Cells
Kameda T
PLoS ONE 2015; 10: e0120774
60077 Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study
Kuwayama Y
Acta Ophthalmologica 2015; 93: e254-e260
60081 Evaluation of filtering blebs exhibiting transconjunctival oozing using anterior segment optical coherence tomography
Hirakawa S
Graefe's Archive for Clinical and Experimental Ophthalmology 2015; 253: 439-445
60077 Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study
Abe H
Acta Ophthalmologica 2015; 93: e254-e260
60081 Evaluation of filtering blebs exhibiting transconjunctival oozing using anterior segment optical coherence tomography
Kojima S
Graefe's Archive for Clinical and Experimental Ophthalmology 2015; 253: 439-445
60687 p38 MAP Kinase Inhibitor Suppresses Transforming Growth Factor-β2-Induced Type 1 Collagen Production in Trabecular Meshwork Cells
Awai-Kasaoka N
PLoS ONE 2015; 10: e0120774
60077 Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study
Suganami H
Acta Ophthalmologica 2015; 93: e254-e260
60081 Evaluation of filtering blebs exhibiting transconjunctival oozing using anterior segment optical coherence tomography
Tanihara H
Graefe's Archive for Clinical and Experimental Ophthalmology 2015; 253: 439-445
60687 p38 MAP Kinase Inhibitor Suppresses Transforming Growth Factor-β2-Induced Type 1 Collagen Production in Trabecular Meshwork Cells
Ohtsu N; Kimoto K
PLoS ONE 2015; 10: e0120774
60077 Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study
Araie M
Acta Ophthalmologica 2015; 93: e254-e260
60687 p38 MAP Kinase Inhibitor Suppresses Transforming Growth Factor-β2-Induced Type 1 Collagen Production in Trabecular Meshwork Cells
Tanihara H
PLoS ONE 2015; 10: e0120774
60077 Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study
Acta Ophthalmologica 2015; 93: e254-e260
